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Henriette Most*
Department of Cardiac and Vascular Surgery, Inselspital University Hospital, Berne, Switzerland
Unloading of the failing left ventricle in order to achieve myocardial reverse remodeling and 
improvement of contractile function has been developed as a strategy with the increas-
ing frequency of implantation of left ventricular assist devices in clinical practice. But, 
reverse remodeling remains an elusive target, with high variability and exact mechanisms 
still largely unclear. The small animal model of heterotopic heart transplantation (hHTX) 
in rodents has been widely implemented to study the effects of complete and partial 
unloading on cardiac failing and non-failing tissue to better understand the structural 
and molecular changes that underlie myocardial recovery. We herein review the current 
knowledge on the effects of volume unloading the left ventricle via different methods of 
hHTX in rats, differentiating between changes that contribute to functional recovery and 
adverse effects observed in unloaded myocardium. We focus on methodological aspects 
of heterotopic transplantation, which increase the correlation between the animal model 
and the setting of the failing unloaded human heart. Last, but not least, we describe 
the late use of sophisticated techniques to acquire data, such as small animal MRI and 
catheterization, as well as ways to assess unloaded hearts under “reloaded” conditions. 
While giving regard to certain limitations, heterotopic rat heart transplantation certainly 
represents the crucial model to mimic unloading-induced changes in the heart and as 
such the intricacies and challenges deserve highest consideration. Careful translational 
research will further improve our knowledge of the reverse remodeling process and how 
to potentiate its effect in order to achieve recovery of contractile function in more patients.
Keywords: heterotopic heart transplantation, myocardial unloading, reverse remodeling, heart failure animal 
model, myocardial recovery
iNTRODUCTiON
Heart failure (HF) is a life-threatening disorder worldwide. In end-stage HF patients, there are no 
curative treatment alternatives to heart transplantation that substantially improve survival. For 
instance, left ventricular assist device (LVAD) implantation can provide powerful circulatory support 
and improve the survival and quality of life compared with the existing pharmacological treatment 
regimen (1). At the same time, these devices result in volume unloading of the ventricle, which 
results in reversal of pathological processes, termed reverse remodeling, to an extent that can allow 
functional recovery of the failing myocardium. In a subset of patients, this allowed explantation 
of the device and prolonged freedom from HF (2, 3). But, prolonged periods of LVAD-induced 
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unloading are also deemed detrimental because they lead to 
cardiac atrophy and increased stiffness of the myocardium (4). 
The complex response to mechanical unloading necessitates a 
reproducible small animal model of mechanical unloading for 
use in the laboratory.
As such, the rat heterotopic heart transplantation (hHTX) 
model has been set up and optimized to study mechanical 
unloading (5–7). This review focuses on adaptations of the 
hHTX model to more closely resemble the human setting, and 
it summarizes the recent advances of preclinical research to 
understand unloading-induced changes in normal and failing 
myocardium and finally specifies optimization of assessment 
modalities.
HeTeROTOPiC HeART 
TRANSPLANTATiON MODeLS  
AND THeiR LiMiTATiONS
Whether the degree of mechanical unloading influences the 
beneficial effects to the heart is under debate: therefore, the idea 
of limiting the duration and intensity of ventricular unloading 
to prevent detrimental effects counteracting efficient reverse 
remodeling has been proposed. Various adaptations of the hHTX 
small animal model to make partial volume unloading possible 
have been developed and applied (Figure 1), allowing compari-
son with complete unloading.
Partial vs. Complete Unloading
Completely Unloaded Left Ventricle
The completely unloaded left ventricle is achieved by using the 
“standard” cardiac heterotopic transplantation technique: an iso-
genic “donor” heart is transplanted infrarenally by anastomosing 
the ascending aorta of the donor end-to-side to the abdominal 
aorta of the “recipient,” within an ischemic time of ∼20  min. 
The pulmonary artery of the transplant is anastomosed end-to-
side to the inferior vena cava. Coronary artery flow antegradely 
perfuses the myocardium, the venous blood returns via the right 
ventricle into the recipients’ circulation, whereas the left-sided 
cavities remain unloaded in this spontaneously beating graft. 
Thus, the left ventricle of heterotopically transplanted hearts is, in 
essence, completely unloaded (Figure 1A). Although this model 
has been applied for decades to study mechanical unloading, 
a recent report indicated that there is a high variability of left 
ventricular volume-loading status, compromising the results. 
The authors report observations from some “unloaded” hearts 
exhibiting considerable ventricular filling and ejection (8).
Partially (Un)Loaded Left Ventricle
A partially unloaded heart model can be achieved by various 
methods. Here, we describe the most frequently and successfully 
used ones, also illustrated in Figure 1:
(a) Partial volume-loading model: the aorta of the donor is 
anastomosed to the abdominal aorta of the recipient, the 
pulmonary artery of the donor to the left atrium of donor, 
and superior vena cava of donor to inferior vena cava of 
recipient (9). This model (Figure 1B) returns some of the 
coronary circulation blood flow to the left ventricle via the 
additional anastomosis, thus allowing for a partial loading of 
the LV. The major disadvantages of this model are require-
ment of an additional anastomosis, resulting in longer 
ischemic time, and the mixture of desoxygenated blood in 
the arterial coronary circulation (10), which has been shown 
to cause LV dysfunction (10).
(b) Heterotopic heart–lung transplantation: the ascending aorta 
“donor” heart is anastomosed to the “recipients” abdominal 
aorta, the “donor” heart’s venae cavae are ligated, and the 
pulmonary artery and pulmonary veins are intact (7). In this 
model (Figure 1C), the left ventricle ejects blood returning 
from the pulmonary circulation and the aortic valve opens 
intermittently. Although there is no available data on the 
oxygen saturation in the blood entering the coronary circu-
lation to date, it can be assumed that this technique results 
in a similar mix of oxygenated and desoxygenated blood as 
in the other known volume-loaded models.
(c) Balloon technique: in a classical heterotopically transplanted 
heart, the left ventricular cavity is filled with a small balloon 
of certain volume to create isovolumic load (11). This model 
(Figure 1D) requires creation of an arterio-venous fistula to 
increase caval oxygen saturation and may result in venous 
thrombosis and thromboembolism.
A load-dependent relationship exists regarding the left ven-
tricular diameters (posterior wall thickness, diastolic interven-
tricular septum, and left ventricular end-diastolic dimension) (7). 
This also affects LV fractional shortening and ejection fraction 
and was further underscored in measurements of the pressure–
volume relation. Significantly, more myocardial atrophy and 
fibrosis were observed in completely unloaded hearts, whereas 
concentrations of cytokines and matrix metalloproteinases were 
comparable in both unloading conditions.
Similarly, chronic partial unloading but not complete 
unloading restored beta-adrenergic responsiveness and reversed 
receptor downregulation in failing rat hearts in a different 
study (12).
The degree and duration of mechanical load variation caused 
by hHTX also regulates cardiomyocyte Ca2+ handling (13): 
Ca2+ release synchronicity was reduced at 8  weeks in partially 
unloaded hearts only. Moderate partial unloading had milder 
effects compared with complete unloading in cell volume reduc-
tion and did not cause depression and delay of the Ca2+ transient, 
increased Ca2+ spark frequency, or impaired t-tubule and cell 
surface structure.
Unwanted effects and Limitations  
of the HTX Model
Heterotopic transplantation of a heart elicits a number of effects 
that can influence the obtained results and have to be taken into 
account when evaluating the unloaded heart.
Systemic Effects
In clinical application, implantation of an LVAD improves whole 
body perfusion and restores neurohormonal activation, this 
being one of the main reasons for the benefit to patients (14). 
FigURe 1 | Depiction of different models of unloading compared with completely unloaded left ventricle. In (A): blood enters the coronary circulation 
antegradely via the anastomosis created between the donor’s ascending aorta and the recipient’s abdominal aorta. Subsequently, venous blood from the coronary 
sinus is ejected into the recipient’s inferior vena cava via the pulmonary artery anastomosis. Due to the closed aortic valve, the left ventricle is unloaded in this model. 
Partial load is achieved in models depicted in (B–D) either by return of the venous coronary blood flow into the left atrium (B) with an additional anastomosis or 
using the pulmonary circulation (C). A different approach is depicted in (D): insertion of a latex balloon via the apex allows differential loading of the left ventricular 
myocardium.
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These systemic beneficial effects cannot be mirrored or observed 
in experimental heterotrophic transplantation models. It could 
be argued that the transplantation of a failing heart into a healthy 
recipient with normal levels of circulating neurohormones and 
intact function of all organs can serve as an example for the nor-
malization occurring in the HF patient on circulatory support 
systems.
Denervation and Heart Rate
Denervation causes beneficial cardiac changes and the beneficial 
effects, such as attenuation of remodeling and functional improve-
ment warrant investigation if this approach can potentially be 
applied to treat HF (15). In the HTX model, the effect of denerva-
tion on the transplanted heart cannot be excluded or differentially 
assessed, as one difference from the clinical setting, in which the 
unloaded heart remains innervated. Therefore, it is critical to 
take the reduced and somewhat fixed heart rate of the grafts into 
account when assessing the functional capacity of the heterotopi-
cally transplanted heart.
Ischemia–Reperfusion Damage
The exposure to I/R is inevitable during HTX in all models, 
reported ischemic times are around 30 min for the conventional 
hHTX (10). During hHTX, ischemic time of each heart is 
FigURe 2 | This diagram illustrates parallel changes in heart failure 
(HF), unloaded normal rat hearts (hHTX), and unloaded failing 
myocardium either from human hearts supported with assist devices 
or from animal experiments (uHF), as well as differences between 
these stages. With respect to cardiac structure and myocardial cell size, 
for instance, changes elicited by unloading are similar in normal and failing 
hearts, a reversal of those seen in failing myocardium.
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different. However, there were no special concerns about the 
ischemia/reperfusion injury reported in most published papers. 
To overcome technical difficulties, which could prolong graft 
ischemia, several improvements have been proposed, such as 
a cuff design system, which allows easy manipulation to man-
age the transplantation with an ischemic time of <11 min on 
average (16).
Immune Reaction/Rejection of the Allograft
After its first description in 1958 (5), the HTX model was com-
monly used for studies assessing transplantation immunology 
(10). Although all studies that examine the effect of left ventricu-
lar unloading use in-bred, isogenic rat strains, for instance Lewis 
rats, the biological effects of this transplantation have not been 
extensively studied.
Lack of Passive Resistance
The introduction of the heart into an abdominal environment, 
which is quite different from original location in the chest, causes 
concern, although the consequences remain unknown to date. 
The passive resistance of pericardial fluid and a pericardial sack 
surrounding the heart is known to cause ventricular interde-
pendence, which must be disrupted in the graft with unknown 
hemodynamic consequences (17).
UNLOADiNg-iNDUCeD eFFeCTS: 
gOOD AND BAD
Mechanical Unloading Leads to 
Adaptation of Cardiac Mass and 
Cardiomyocyte Size
In clinical practice, as one of the many features of LVAD 
supported failing hearts, a shrinkage of the enlarged heart is 
consistently observed (18). This reduction of the overall cardiac 
mass is the most distinct and consistent phenomenon (18), and 
it has been replicated and investigated in the hHTX model 
(Figure 2).
In hypertrophic and failing hearts, unloading reverses patho-
logical enlargement of cardiac myocytes and normalizes myocar-
dial mass, while in heterotopically transplanted normal hearts, we 
find reduction of cellular diameters as well as a relative decrease 
of myocytes compared with connective tissue, this being termed 
atrophy (19, 20). While the normalization of hypertrophy in the 
failing unloaded heart can be explained by the disappearance of 
increased wall stress, which goes along with the initiation of a 
similar gene expression program in both hypertrophy and after 
unloading (21), the atrophy following unloading of a normal rat 
heart must be an active adaptation to the loss of volume load, 
which includes autophagy and apoptosis (22).
Apoptosis in Mechanically Unloaded 
Hearts
A progressive decline in LV function has been linked to loss of 
nearly one-third of all cardiomyocytes as a result of apoptosis 
in cardiomyopathy, both in human (23) and in animal HF, with 
both proapoptotic and antiapoptotic pathways being activated 
in advanced HF (24). Basic and translational research shows 
contradictory findings on the effects of LVAD unloading on 
apoptosis to date (25), as programmed cell death constitutes part 
of the underlying disease with heterogenic pathology (Figure 3).
In a study investigating mechanically unloaded dilated car-
diomyopathy (DCM) hearts in the hHTX model, the TUNEL-
positive myocyte count indicated that there was no difference 
after 2 weeks of unloading. However, 4 weeks after unloading, the 
number of TUNEL-positive myocyte in DCM-unloaded group 
was higher than that in the DCM group (26). The underlying 
mechanisms are not clear. It was reported that there is a sig-
nificant increase in caspase-3 mRNA expression and activity after 
mechanical unloading in a normal unloaded heart (22, 27, 28). In 
addition, relatively late expression changes in genes involved in 
the apoptosis process were found at the protein level. Increased 
protein expression of bax resulted in a higher apoptotic index 
(bax/bcl-2 ratio) after 30 and 60 days of unloading. Expression of 
the antiapoptotic protein bcl-2 was only decreased at the mRNA 
level, but not at the protein level (22).
In the small animal model, the rate of apoptotic cell death 
is reduced in unloaded failing hearts (29), as a result of 
diminished toxic catecholamine overstimulation and improved 
energy metabolism. But, somewhat astonishingly, it was found 
that unloaded normal hearts exhibit increased apoptosis after 
prolonged unloading time (22). This speaks toward a late induc-
tion of apoptosis as the result of disuse and might indicate that 
the beneficial changes that lead to reverse remodeling in the 
failing heart could be counterbalanced by detrimental reduction 
of cardiomyocytes with prolonged periods of unloading.
FigURe 3 | Regarding atrophy, apoptosis, and autophagy, we find 
more similarities between unloaded normal rat hearts and failing 
hearts, since apoptosis and atrophy are induced in HF, but were also 
seen in rat myocardium after hHTX. On the other hand, markers of 
autophagy were induced in a similar way in hHTX and unloaded failing 
hearts, indicating regulation of changes that are possibly counteracting each 
other in hHTX.
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Autophagy
Autophagy was induced during regression of cardiac hyper-
trophy, as evidenced by an increase in microtubule-associated 
protein 1 light chain 3 (LC3)-II protein level. Cardiac-specific 
Atg5-deficient (CKO) mice showed significantly less regression 
of cardiac hypertrophy compared with normal controls (30). 
Sadoshima’s group found that the FoxO family of transcription 
factors is involved in autophagy during mechanical unloading of 
the heart. Transgenic mice with cardiac-specific overexpression 
of FoxO1 exhibited smaller hearts and upregulation of autophagy 
(31). Autophagy-mediated degradation also seemed necessary for 
regression of cardiac hypertrophy during ventricular unloading. 
By hHTX of normal rat hearts, Cao et al. found autophagy was 
activated via transcription factor FoxO3 and bnip3 in unloaded 
hearts (32), which went along with the reduction of mitochon-
drial proteins.
Razeghi et al. indicated that both protein synthesis and deg-
radation were activated in heterotopically transplanted rat hearts 
(19). Atrophic changes seemed to change the balance of protein 
synthesis and degradation and inhibition of the involved signaling 
pathway downstream of mTOR by Rapamycin led to augmented 
atrophy even (19). Unloading seems to initiate processes leading 
to a new steady state after 30 days (19, 20), at which a maintenance 
of cardiac mass seems to be reached.
Ligases of the ubiquitin system, such as MuRF1 and 
Atrogin-1/MAFbx, are also involved in the atrophic changes 
(33) via autophagy. Protein degradation was not significantly 
altered in unloaded hearts lacking Atrogin-1/MAFbx (Atrogin1/
MAFbx−/−), but protein synthesis was dramatically elevated 
in atrogin1/MAFbx-deficient cardiomyocytes. Calcineurin 
and NFAT activity were significantly increased in Atrogin-1/
MAFbx−/− CMs (33).
In human failing hearts, mechanical unloading resulted in 
a decrease of markers of autophagy, suggesting that autophagy 
may be a maladaptive mechanism in the failing hearts, which is 
attenuated by LVAD support (34). This is also supported by the 
knowledge that autophagy plays an essential role in mediating 
regression of hypertrophy during unloading of the heart (31, 35). 
Chronic activation of autophagy can lead to excessive degrada-
tion of critical cellular proteins and organelles, which will induce 
cell death. The complex role of autophagy in the unloaded failing 
heart needs to be further investigated.
The term atrophy currently denominates a “side-effect” of 
mechanical unloading. Although primarily on the basis of animal 
data, the notion that chronic LVAD-induced unloading will result 
in atrophy has dominated the clinical HF field, and antiatrophic 
drugs have been used to enhance the cardiac recovery potential 
in LVAD patients (36).
Antiatrophic Pharmacological Therapy 
with Mechanical Unloading
Since the treatment with LVAD alone is not sufficient in eliciting 
and exploiting the potential for recovery in most chronic HF 
patients, adjunct complimentary and combination therapy have 
been proposed (37). Clenbuterol has been investigated in the 
small animal hHTX model as well as in clinical trials: a rationale 
for a potential beneficial antiatrophic effect was the known ana-
bolic capacity of Clenbuterol and other β2-adrenergic agonists. 
In the hHTX model, it significantly increased the weight of the 
recipient rat hearts, but did not prevent unloading-induced LV 
atrophy in the transplanted heart (38, 39). There was no differ-
ence in LV developed pressure between the Clenbuterol-treated 
and control group. However, Clenbuterol treatment improved 
gene expression (SERCA2a, beta-MHC) and beta-adrenergic 
responsiveness and potentially prevented myocardial apoptosis 
(38). Thus, the combination of Clenbuterol with mechanical 
unloading seemed promising in HF. In the small animal model, 
adjunct treatment with Clenbuterol increased sarcomere short-
ening by normalizing the depressed myofilament sensitivity to 
Ca2+ in cardiomyocytes. Clenbuterol limited unloading-induced 
reduction of cell size, which further supported the rationale 
for its use to limit unloading-induced myocardial atrophy 
(39). Furthermore, Clenbuterol, if combined with a β1 blocker 
(Metoprolol) and mechanical unloading enhanced functional 
recovery via improvement in ejection fraction (EF) while pre-
venting Clenbuterol-induced hypertrophy and tachycardia. But, 
at closer observation, the results of this investigation were not 
consistent: during mechanical unloading, the combined phar-
macological therapy was less beneficial than either monotherapy 
in preventing myocardial atrophy. Metoprolol, not Clenbuterol, 
prevented unloading-induced myocardial atrophy, with increased 
atrophy occurring during combined therapy. Unloading-induced 
recovery of Ca2+ transient amplitude, speed of Ca2+ release and 
sarcoplasmic reticulum Ca2+ content was enhanced equally by 
each monotherapy, but these benefits, together with Clenbuterols 
enhancement of sarcomeric contraction speed, and unloading-
induced recovery of Ca2+ spark frequency disappeared during 
combined therapy (40).
Promising data from several clinical trials of the London 
Harefield group around Magdi Yacoub have not lived up to its 
promise, largely, because the results could not be replicated 
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to the full extent at other centers (3). A potential explanation 
would be that atrophy is not necessarily associated with either 
recovery/regression of the failing heart (41) or deleterious effect 
of unloading (22). If so, atrophy cannot be used as an indicator for 
recovery or maladaptation. Further detailed mechanisms need to 
be investigated. Of course, atrophy of the unloaded normal heart 
cannot simply explain the dynamics in LVAD supported failing 
hearts, since it cannot mimic the confounding effects of specific 
pathologies leading to HF.
Early preclinical data exist for beneficial effects of innovative 
pharmacological and cell therapy in the setting of unloading-
induced myocardial recovery: ivabradine, combined with 
mechanical unloading was shown to reverse myocardial fibrosis 
and enhance the restoration of deranged E–C coupling (42) in 
one study using the small animal hHTX model. Also, hHTX was 
combined with cell therapy, where mechanical unloading in mice 
via hHTX was able to increase survival rate and differentiation of 
cardiac stem cells after implantation (43). Another agent previ-
ously successfully used in HF therapy, thyroid hormone (T3) at 
physiological doses restored depressed contractile reserve and 
impaired calcium handling of cardiac myocytes from chronically 
unloaded hearts (44, 45). These findings require more rigorous 
and in-depth testing, but reveal the worth of the hHTX model to 
provide a great opportunity to investigate several potential treat-
ments with mechanical unloading. This model strongly impacts 
preclinical studies to validate ideas and illustrate potential effects 
with new combinations.
Metabolic Changes in Unloaded Hearts
In theory, when the heart is unloaded, metabolic alterations 
reflect the decreased energy demand of the cardiac muscle and 
also its compromised capacity to generate sufficient amounts 
of adenosine triphosphate (ATP). Similarly, the failing heart 
develops alterations of metabolism, such as compromised glucose 
uptake and fatty acid oxidation as one of the maladaptive features 
distinctive of HF. If the mechanical unloading of myocardium can 
ameliorate or aggravate metabolic changes in the failing heart, is 
a key question to be addressed.
In failing human hearts, metabolic effects lead to impaired 
substrate utilization and subsequent disturbance of energy home-
ostasis (46). Comparison of myocardial samples taken before 
and after LVAD implantation revealed that unloading improved 
decreases in key transcription factors and their target enzymes 
critical to cardiac metabolism (47). Whether the unloaded heart 
can keep the flexibility to respond to different energy demand 
needs to be further investigated.
generation of energy Substrates
Glucose and fatty acids are both main energy substrates for 
the heart. In the healthy adult myocardium, β-oxidation of 
fatty acids accounts for about 70% of the ATP generation (48). 
However, per molecule of ATP, oxidation of glucose requires 
less oxygen, thus increasing efficiency up to 25%. In hyper-
trophied and failing hearts, a characteristic switch of Myosin 
heavy chain isoforms occurs and limits performance. This 
switch in favor of α-MHC, called fetal expression pattern, was 
also found in mechanically unloaded hearts (21). Therefore, it 
was proclaimed that a correlation exists between the adaptation 
of energy-consuming and energy-producing pathways in both 
hypertrophy and unloading (49).
Further supporting this notion, it was reported that mechani-
cal unloading led to remarkably diminished glucose uptake (7, 
9) in completely unloaded myocardium, but not in partially 
unloaded LV myocardium (9), although these data were not 
reproduced yet. One study claimed that glucose transporter type 1 
(GLUT-1, fetal type) mRNA increased in the unloaded heart with 
no changes in glucose transporter type 4 (GLUT-4, adult type) 
mRNA (Figure 3). The other report discovered that GLUT-4 was 
decreased in unloaded hearts; however, GLUT-1 remained the 
same as the control (9, 21). GLUT-4 is the main isoform found in 
the normal adult heart. The decrease of GLUT-4 in the unloaded 
hearts reflects the decrease in energy needs.
Although it looks like alterations in transcription patterns of 
metabolic genes account for the substrate preference shift from 
fatty acids to glucose in the atrophic heart, the mechanism of 
this shifting is not completely understood. For instance, there is 
no convincing evidence for increasing expression of glycolytic 
enzymes in unloaded cardiomyocytes to support previous 
hypotheses. Whether glycolysis is enhanced or not in unloaded 
heart is currently not known.
Mitochondrial Detrimental effects
The precise temporal activation of metabolic effects during 
mechanical unloading is largely not clear to date. It was shown 
that mitochondrial protein expression is diminished in unloaded 
hearts with ongoing atrophy (50). During atrophic myocardial 
changes, mitochondrial damage caused by increased mito-
chondrial uncoupling protein activity or increased production 
of reactive oxygen species reduces ATP production and leads 
to metabolic dysfunction. Consistent with this, mechanical 
unloading of the failing heart does not restore the transcript lev-
els of metabolic genes with the notable exception of uncoupling 
protein 3 (UPC3) (51). On the other side, UPC2 and mitochon-
drial transmembrane proteins that create a proton leak which 
uncouples ATP synthesis from the electron transport chain is 
decreased in pathological remodeling (52). In addition, during 
cardiac atrophy, expression of peroxisome proliferator-activated 
receptor-α (PPAR-α) and PPAR-coactivator-1α (PCG-1α) 
activity are decreased (53). This reduction predicates reduced 
mitochondrial gene expression and reduced oxidative capacity. 
And this could be another reason for the metabolic crisis in 
atrophied hearts.
AMP-activated protein kinase (AMPK), which is the meta-
bolic master switch regulating several intracellular systems 
including the cellular uptake of glucose, the β-oxidation of fatty 
acids, was recently investigated in heterotopically transplanted 
hearts. A reduced ATP-to-AMP ratio will activate AMPK signal-
ing in cardiomyocytes. In a study investigating a role for AMPK 
in cardiac autophagy and protein degradation induced in vitro 
by starvation, it was shown that AMPK-induced expression of 
ubiquitin ligases MuRF1 and Atrogin-1, which resulted in cardio-
myocyte dysfunction (49). While these ligases are also strongly 
involved in unloading-induced shrinking of the heart, the role of 
AMPK remains unclarified to date.
FigURe 4 | effects of unloading to sarcomeric function and Ca2+ 
cycling indicate more detrimental changes in unloaded normal rat 
hearts, similar to remodeling in HF. For instance, Ca2+ cycling and 
adrenergic signaling are negatively impacted in both HF and after hHTX, as 
opposed to the reverse remodeling process seen after LVAD implantation.
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Ca2+ CYCLiNg AND CONTRACTiLe 
FUNCTiON iN THe UNLOADeD 
CARDiOMYOCYTe
enhanced Ca2+ influx through Cardiac 
L-Type Ca2+ Channels
Excitation–contraction coupling in cardiomyocytes requires 
appropriate Ca2+ handling and sarcomeric protein expression 
and assembly. Intracellular Ca2+ transients are pivotal to electro-
mechanical coupling and to cardiac plasticity (54–56). Whether 
Ca2+ transients are changed will critically influence contractile 
function in mechanically unloaded hearts.
Although certain decreased expression of proteins implicated 
in Ca2+ regulation, the shape of the systolic Ca2+ transient remains 
unaltered after atrophic transformation (57, 58). Data on the par-
ticulars of Ca2+ transients, i.e., the amplitude, the diastolic Ca2+ 
concentration, as well as the time course of the Ca2+ transients, are 
not consistent: some found them not to be significantly different 
between unloaded hearts and controls (58), while others found 
that the peak amplitude of the whole-cell Ca2+ transient was 
significantly smaller after hHTX unloading (59). The variance of 
time-to-peak of the Ca2+ transients was significantly increased 
in unloaded cardiomyocytes, suggesting that the synchronicity 
of Ca2+ release was disrupted. L-type Ca2+ current density was 
unaffected, and inactivation was delayed (59).
In myocytes isolated from atrophic hearts, the amplitude of 
transient inward current (Iti) (peak Iti) was significantly lower 
than in control myocytes (10% in endocardial and 50% in 
epicardial myocytes). Sarcoplasmic reticulum (SR) Ca2+ content 
was reduced by ~55% in unloaded hearts (58). Atrophic cardiac 
myocytes showed a 45% lower frequency of spontaneous dias-
tolic Ca2+ sparks. Quantification of spontaneous Ca2+ release 
in control and thapsigargin-treated cardiac myocytes revealed 
that the partial depletion of the SR caused a ~65% lower mean 
Ca2+ spark frequency and a 2.5-fold higher fraction of cells 
with a very low spark activity. Ryanodine receptor expression 
was significantly increased (130% of control) in the atrophic 
myocardium, whereas its phosphorylation at Ser2814 was unal-
tered (58). These data suggest that, in early cardiac atrophy 
induced by mechanical unloading, an augmented sarcolemmal 
Ca2+ influx through LTCC compensates for a reduced systolic 
SR Ca2+ release to preserve the Ca2+ transient amplitude. This 
interplay involves an electrophysiological remodeling as well 
as changes in the expression of cardiac ion channels. In this 
thorough study, it was also hypothesized that the unaffected 
Ca2+ transients in spite of a decreased SR Ca2+ content could 
be a consequence of an unaltered absolute amount of Ca2+ 
released from the SR during systole. The Ca2+ transient in 
atrophic cardiac myocytes must be maintained by a compen-
satory mechanism other than an increased fractional release 
from the SR.
Another explanation for unchanged Ca2+ transients in the 
presence of a reduced SR Ca2+ load is an increased Ca2+ influx 
during the action potential (AP). Schwoerer et al. indicate that 
in atrophic cardiac myocytes Ca2+ influx through the L-type Ca2+ 
channel (LTCC) is augmented both by an increased electrical 
driving force caused by prolonged APs and by an increased 
membrane abundance of Ca2+ channel subunits.
The Action Potential in Unloaded 
Cardiomyocytes
Unloaded rat hearts displayed markedly prolonged APs with a 
pronounced plateau phase (58). Known mechanisms underlying 
prolonged APs are often changes in the repolarizing K+ current, 
in particular, of the transient outward K+ current (Ito). The reduc-
tion of Ito can be associated with significantly lower levels of Kv4.2 
and Kv4.3 mRNAs in epicardial myocytes and of KChIP2 mRNA 
in endocardial myocytes. Current clamp recordings revealed pro-
longed APs in endocardial as well as epicardial myocytes, which 
were associated with a twofold to fourfold higher sarcolemmal 
Ca2+ influx during the AP. In addition, Caveolin 1.2 subunits, 
which form the pore of the LTCC, were upregulated in atrophic 
myocardium.
Mechanical Unloading Reverses Certain 
electrophysiological Features of HF
Ca2+-induced Ca2+ release (CICR) is critical for effective con-
traction in cardiomyocytes. The transverse (t)-tubule system 
guarantees the proximity of the triggers for Ca2+ release (LTCC, 
dihydropyridine receptors) and the SR Ca2+ release channels 
(ryanodine receptors). Transverse-tubule disruption occurs early 
in HF, and the typically reduced t-tubule density was reversed by 
unloading (59): both the decreased density and also the deterio-
ration in the regularity of the t-tubule system were reversed by 
mechanical unloading (Figure 4).
In a follow-up study, Ibrahim and colleagues evaluated L-type 
Ca2+ current density in unloaded failing hearts, measured using 
whole-cell patch clamping, and observed that it was reduced in 
HF, but this was unaffected by unloading in contrast to the normal 
FigURe 5 | Changes in the extracellular matrix plays a crucial role 
in the development and progression of HF, and key elements of 
pathological remodeling such as increased neurohormone and 
growth factor expression are also found in the small animal model 
of hHTX, whereas these changes were reversed in LvAD-unloaded 
human failing myocardium.
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unloaded hearts (60). Scanning ion conductance microscopy 
revealed reappearance of normal surface striation in unloaded 
failing hearts. Electron microscopy showed recovery of normal 
t-tubule microarchitecture in that same study. The variance of 
the time-to-peak of the Ca2+ transient, an index of CICR dys-
synchrony, was increased in HF and normalized by unloading. 
The increased Ca2+ spark frequency observed in HF was reduced 
via unloading. These results were explained by the recoupling 
of orphaned RyRs in HF, as indicated by immunofluorescence. 
Taken together, the authors concluded that mechanical unload-
ing of the failing heart reversed the pathological remodeling of 
the t-tubule system and improved CICR (60).
Following a different therapeutic adjunct to unloading, it 
was suggested that physiological treatment dose of thyroid hor-
mone rescued the impaired myocyte relaxation and depressed 
contractile reserve at least partially through the restoration of 
phospholamban (PLB) protein levels and its phosphorylation 
state in chronically unloaded hearts (44). In vehicle-treated ani-
mals, myocyte relaxation and Ca2+ decay were slower in unloaded 
hearts than in recipient hearts. Myocyte shortening in response 
to high Ca2+ was also depressed with impaired augmentation of 
peak-systolic Ca2+ influx in unloaded hearts compared with con-
trol. In vehicle-treated rats, protein levels of PLB were increased 
by 136% and the phosphorylation of PLB decreased by 32% in 
unloaded hearts. In the thyroid hormone-treated animals, these 
features leading to depressed contractile reserve in myocytes 
from unloaded hearts were all returned to normal levels (44).
Takaseya and colleagues reported that mechanical unload-
ing increases SR Ca2+ ATPase and improves Ca2+ handling and 
contractility in rats with doxorubicin-induced cardiomyopathy. 
These beneficial effects of mechanical unloading were not 
observed in normal unloaded hearts (61).
Summarizing these data, one might conclude that our cur-
rent knowledge indicates a beneficial role for unloading on Ca2+ 
cycling and E–C coupling in failing myocardium, while the 
atrophic changes induced in normal hearts via hHTX lead to 
perturbations deleterious to its Ca2+ homeostasis.
Unloading-induced Recovery of 
Adrenergic Responsiveness
The failing myocardium is characterized by decreased force 
generation and slowed relaxation as a consequence of depressed 
response to β-adrenergic stimulation. Studies comparing failing 
and unloaded failing human hearts confirmed a certain improve-
ment of β-adrenergic response and subsequent contractile 
properties many times over (62, 63). The underlying reversion 
of pathological adrenergic signaling and responsiveness of the 
contractile apparatus of cardiomyocytes can be studied in the 
small animal model (6), but a detailed and accurate assessment 
of density and activity of β-adrenergic receptors and coupling to 
adenylyl cyclase is still missing.
With particular interest given to unloading time, Oriyanhan 
and colleagues studied functional recovery in a rat ischemic HF 
model with unloading times of 2, 4, and 8 weeks and found that 
the maximal inotropic response occurred at 4 weeks in isolated 
papillary muscles from unloaded failing hearts (29). In paral-
lel to the approach in humans, Soppa and colleagues reported 
therapeutic potential on Clenbuterol on unloaded failing rat 
hearts after 7 days: the sensitivity to Ca2+ and sarcomere shorten-
ing were superior in Clenbuterol-treated hearts, but the density 
and activity of β-adrenergic receptors was not reported (39).
In a study using a partially unloaded hHTX model, developed 
tension of posterior papillary muscle was significantly increased 
in the partially unloaded group compared with the HF group 
(64). The mRNA expression of brain natriuretic peptide (BNP), 
SERCA2a, and β1- and β2-adrenergic receptors (β1- and β2-AR) 
in LV tissue was almost normalized in partially unloaded hearts.
eXTRACeLLULAR MATRiX 
ReORgANiZATiON wiTH MeCHANiCAL 
UNLOADiNg
The extracellular matrix (ECM) of cardiac tissue is comprised 
mainly of collagen type I, elastin, proteoglycans, and glyco-
proteins and is integral to the maintenance of tensile strength 
and myofibrillar organization of cardiac muscle (65). Because 
intimate connections between the cardiomyocytes and ECM are 
required to coordinate contraction of the myocardium, cardiac 
structural rearrangement cannot be limited to the cardiomyo-
cytes; decreased cardiomyocyte volume alters the relationship 
between cells and the ECM. Changes in the ECM composition 
and collagen turnover, largely a result of balancing matrix metal-
loproteinases (MMP-1, -2, and -9) and tissue-inhibitor of matrix 
metalloproteinases (TIMP-2 and -3) activation, after mechanical 
unloading of failing and normal hearts have been characterized.
Observations in failing human hearts indicate a beneficial 
regression of fibrosis and myocardial stiffness in hearts unloaded 
via LVAD (66, 67), as one of the reasons for partial recovery of 
function (Figure 5). A correlation between changes in HF patient 
myocardium after LVAD, such as increases in connective tissue 
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growth factor-, alpha 3 collagen-, and osteonectin-mRNA, with 
results found in the unloaded normal rat hearts may be estab-
lished (22, 67).
After unloading of rat hearts with ischemic HF via coronary 
artery ligation, mRNA levels of MMP-1, -2, and -9 were normal-
ized, and TIMP-2 and TIMP-3 were upregulated compared with 
HF (68). This led to a normalization of the MMP/TIMP ratio, 
indicative of beneficial reverse remodeling. Quite contrary, in 
normal unloaded hearts, mRNA expression of MMP-2 and 
MMP-9 increased on the 7th and 14th days after heart transplan-
tation and peaked on the 14th day compared with the control 
group. The gelatinase activity as well as myocardial ECM deposi-
tion significantly increased with duration of unloading. Although 
both mRNA and protein levels of TIMP-1 and TIMP-2 were also 
increased, it was proclaimed that mechanical unloading may 
lead to adverse remodeling of the ECM of the left ventricle, the 
underlying mechanism being an imbalance of the MMP/TIMP 
system, especially taking into account the remarkable upregula-
tion of TIMPs in the pressure and volume unloaded heart (69). 
Additionally, we recently found that mRNA expression level of 
fibroblast growth factor (FGF-2) was significantly increased after 
prolonged unloading (22), potentially further promoting fibrosis 
of the myocardium. Furthermore, in the small animal model 
of hHTX, after left anterior descending artery ligation induced 
HF, Oriyanhan et al. found that myocardial fibrosis of the failing 
heart increased further after unloading (29). Similar results were 
repeatedly found with myocardial infarction or DCM-induced 
HF and unloading hHTX models (26, 64).
On the other hand, expression of the fetal genes, atrial natriu-
retic factor (ANF) or brain natriuretic peptide (BNP), which are 
upregulated not only in HF but also in atrophic myocardium, has 
been shown to oppose myofibroblast activity. Activated myofi-
broblasts enhance the synthesis and secretion of type I fibrillary 
collagen (65), an increased expression of matrix proteins after 
unloading was observed to cause myofibrillar disarray and 
excessive ECM, which negatively affects cardiac function causing 
tissue stiffness (70). These findings are supporting the notion that 
the initial response to hemodynamic unloading may be cardio-
protective in nature and that a beneficial effect of unloading may 
be time dependent (71).
However, detailed ECM configuration affecting car-
diomyocytes, cardiac fibroblasts, and cardiac function need to 
be investigated in more detail. It is important to emphasize that 
the development and reduction of fibrosis is thought to be of 
paramount importance in recovery of function. Again, the HTX 
model and its variations remain the most critical preclinical 
models to study these intricate mechanisms.
iMAgiNg MODALiTieS AND FUNCTiONAL 
ASSeSSMeNT TeCHNiQUe
While the changes in molecular and cellular remodeling can be 
assessed well with standard techniques, the correct and reliable 
assessment of myocardial contractile function is one of the most 
critical issues remaining to be solved. Because of the charac-
teristic lack of load, the standard methods to visualize cardiac 
function using echocardiography and catheterization to acquire 
hemodynamic data mostly fail to provide valid and reproduc-
ible data. Here, we report conventional methods and propose 
innovative ways to assess heart function in the heterotopically 
transplanted heart.
imaging
Transabdominal Echocardiography
Because of its non-invasive nature, possibility of repetitive 
measurements and relative cost-effectiveness, echocardiography 
is the most common assessment of dimensions and function of 
the cardiac graft after unloading (72). Small animal echocardi-
ography relies heavily on the use of advanced technology and 
equipment, such as a 20-MHz transducer for high resolution 
and imaging quality. The disadvantages of this method include 
the high variability of acquired data relying on experience of the 
examiner, well-defined planes of measurement, anatomic varia-
tion, and adjustment of technical equipment. Most researchers 
try to minimize these downsides by repetitive measurements.
Magnetic Resonance Tomography
Unlike other cardiovascular imaging techniques, cardiovascular 
MRI can give access to parameters characterizing morphology, 
global and regional function, blood flow, myocardial structure, 
cell damage, metabolism, and other molecular processes in 
rodents. MRI is rapidly gaining importance as a non-invasive 
tool for functional and structural assessment of myocardium, 
with potential new information gained from cine-MRI analysis 
(9). The necessary know-how and technical equipment for rodent 
MRI is described in detail in an excellent review (73).
Hemodynamic and Metabolic Functional 
Assessment
The HTX model gives us an opportunity to closely check the 
hemodynamic and metabolic changes in mechanically unloaded 
myocardium. With advanced imaging techniques, such as 
positron emission tomography (PET) or MRI, we are able to 
assess indicators of metabolic changes (7, 9). This will improve 
our knowledge of dynamic changes induced in the HTX model 
and help us to understand the complexity and multiple affected 
structures more adequately.
Isolated Cardiomyocyte Function
To distinguish between effects of unloading on the single 
contractile unit of the heart, the cardiomyocyte in contrast to 
changes in the organ level mediated by overall shrinking of the 
heart and myocardial fibrosis and decreased compliance, analysis 
of the isolated myocyte function is crucial. Shortening of the 
sarcomeres can be analyzed by videorecording of the contraction 
and its depiction as a transient, allowing assessment of fractional 
shortening and relaxation as well as sarcomere length (59, 74).
Pressure–Volume Relation
The most rigorous hemodynamic evaluation of cardiac func-
tion is  acquired via conductance catheter insertion generating 
 pressure–volume relationship data (75). Valuable data can be 
derived from pressure–volume loop analysis in volume-loaded 
hearts, but the acquisition of pressure–volume loops from 
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volume-unloaded hearts bears intrinsic potential for fault due 
to the lack of volume itself. This represents an important limita-
tion for this method in heterotopically transplanted, completely 
unloaded hearts. The tracings from a conductance catheter reveal 
the almost complete lack of volume in the completely unloaded 
hearts (9). Another one of the rare studies employing  pressure–
volume loop analysis in completely and partially unloaded rat 
hearts to date by Liu et  al. (7) reported lower cardiac output, 
stroke work, and volume in completely unloaded hearts, correlat-
ing with lower metabolic activity.
Positron Emission Tomography
Atrophic changes in chronically unloaded hearts characteristi-
cally include upregulation of the fetal isoform of the glucose 
transporter GLUT1 (9). Cardiac glucose utilization mirrors work 
load and thus FDG-PET may be used to assess the metabolic 
consequences of complete and partial unloading of the heart (9). 
In two published examinations, FDG-PET was not consistent in 
revealing differences between unloaded and partially unloaded 
myocardium (7, 9). There was, however, a correlation between 
metabolic activity and stroke work, which was lower in com-
pletely unloaded hearts compared with partially volume-loaded 
hearts (7).
Isolated Working Heart
After chronic unloading of the left ventricle with either model 
of hHTX, assessment of the contractile function under reloaded 
conditions remains a major issue. Still, all translational research 
efforts aiming at exploitation of the HTX model to mimic the 
therapeutic effects of unloading rely on such information as the 
ultimate endpoint. The isolated working heart model represents 
a possibility to control volume-load and perfusion pressure and 
thus poses the ideal method to assess the functional capacity 
of the unloaded heart (76). Although the proper retrieval and 
subsequent cannulation of the hearts is challenging, this method 
offers most valuable knowledge of the hearts remaining capacity 
to sustain under volume reloading.
CONCLUSiON
This review points to several aspects of unloading as a potentially 
therapeutic strategy in severe HF: our summary of effects on the 
organ structure, cellular features, and molecular changes decipher 
myocardial unloading as an active remodeling process. It shares 
both aspects of HF and its pathognomonic cellular and molecular 
features as well as of the reverse remodeling induced by LVADs, 
with may indicate a recovering heart. So far, the field is still in 
search of key factors signifying recovery potential. One reason 
might be the significant differences between the hHTX model 
and the human setting, which has been addressed by several 
developments of the model in order to more accurately mimic 
the unloading of human myocardium, and we have depicted 
these, offering some advantages. Novel strategies to assess and 
analyze the unloaded rodent heart will definitely increase the 
impact of hHTX as a model in the future, spurned by the desire 
to elucidate the basis of myocardial recovery and advancing it 
toward a relevant clinical therapeutic strategy.
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